150 related articles for article (PubMed ID: 37829270)
1. Rapidly growing uterine myoma - should we be afraid of it?
Nowak M; Bartosik W; Witana W; Nowak K; Wilkusz J
Prz Menopauzalny; 2023 Sep; 22(3):161-164. PubMed ID: 37829270
[TBL] [Abstract][Full Text] [Related]
2. The management of uterine leiomyomas.
Vilos GA; Allaire C; Laberge PY; Leyland N;
J Obstet Gynaecol Can; 2015 Feb; 37(2):157-178. PubMed ID: 25767949
[TBL] [Abstract][Full Text] [Related]
3. Uterine artery embolization as a treatment option for uterine myomas.
Marshburn PB; Matthews ML; Hurst BS
Obstet Gynecol Clin North Am; 2006 Mar; 33(1):125-44. PubMed ID: 16504811
[TBL] [Abstract][Full Text] [Related]
4. A Prospective Intervention Trial on Tailored Radiofrequency Ablation of Uterine Myomas.
Fasciani A; Turtulici G; Siri G; Ferrero S; Sirito R
Medicina (Kaunas); 2020 Mar; 56(3):. PubMed ID: 32178351
[No Abstract] [Full Text] [Related]
5. The management of uterine leiomyomas.
Lefebvre G; Vilos G; Allaire C; Jeffrey J; Arneja J; Birch C; Fortier M; Wagner MS;
J Obstet Gynaecol Can; 2003 May; 25(5):396-418; quiz 419-22. PubMed ID: 12738981
[TBL] [Abstract][Full Text] [Related]
6. Uterine Myoma Position-based Radiofrequency Ablation (UMP-b RFA): 36 months follow-up clinical outcomes.
Fasciani A; Turtulici G; Pedullà A; Sirito R
Eur J Obstet Gynecol Reprod Biol; 2023 Feb; 281():23-28. PubMed ID: 36527825
[TBL] [Abstract][Full Text] [Related]
7. Ultrasound features of highly vascularized uterine myomas (uterine smooth muscle tumors) and correlation with histopathology.
Russo C; Camilli S; Martire FG; Di Giovanni A; Lazzeri L; Malzoni M; Zupi E; Exacoustos C
Ultrasound Obstet Gynecol; 2022 Aug; 60(2):269-276. PubMed ID: 35018681
[TBL] [Abstract][Full Text] [Related]
8. The effect of a gynecologist-interventional radiologist relationship on selection of treatment modality for the patient with uterine myoma.
Zurawin RK; Fischer JH; Amir L
J Minim Invasive Gynecol; 2010; 17(2):214-21. PubMed ID: 20226411
[TBL] [Abstract][Full Text] [Related]
9. Incidence of occult uterine sarcoma and other unexpected pathologies in patients having surgery for presumed myomas: A retrospective observational study.
Mühlenbrock MV; Navarrete-Rey P; Kovoor E; Guzman-Rojas R; Troncoso F; Miranda-Mendoza I
J Gynecol Obstet Hum Reprod; 2021 Sep; 50(7):101992. PubMed ID: 33217603
[TBL] [Abstract][Full Text] [Related]
10. Morbidity, fertility and pregnancy outcomes after myoma enucleation by laparoscopy versus laparotomy.
Kundu S; Iwanuk C; Staboulidou I; Garcia-Rocha GJ; Soergel P; Hertel H; Hillemanns P; Schippert C
Arch Gynecol Obstet; 2018 Apr; 297(4):969-976. PubMed ID: 29417281
[TBL] [Abstract][Full Text] [Related]
11. Sonographic Monitoring of Growth of Uterine Myomas in Untreated Women and Respective Influence Factors.
Seidel V; Wernecke KD; Bellingkrodt AL; Armbrust R; David M
Geburtshilfe Frauenheilkd; 2023 Apr; 83(4):446-452. PubMed ID: 37034415
[No Abstract] [Full Text] [Related]
12. Symptoms of uterine myomas: data of an epidemiological study in Germany.
Foth D; Röhl FW; Friedrich C; Tylkoski H; Rabe T; Römer T; Kitay A; Ahrendt HJ
Arch Gynecol Obstet; 2017 Feb; 295(2):415-426. PubMed ID: 27873052
[TBL] [Abstract][Full Text] [Related]
13. Feasibility of quantitative MR-perfusion imaging to monitor treatment response after uterine artery embolization (UAE) in symptomatic uterus fibroids.
Sadick M; Richers J; Tuschy B; Schad LR; Schoenberg SO; Zöllner FG
Magn Reson Imaging; 2019 Jun; 59():31-38. PubMed ID: 30807812
[TBL] [Abstract][Full Text] [Related]
14. Laparoscopic Uterine Artery Occlusion Combined with Uterine-sparing Pelvic Plexus Block and Partial Adenomyomectomy for Adenomyosis: A Video Case Report.
Chen D; Ai G; Yang W; Liu J; Luo N; Guo J; Cheng Z
J Minim Invasive Gynecol; 2021 Oct; 28(10):1681-1684. PubMed ID: 34051355
[TBL] [Abstract][Full Text] [Related]
15. Efficacy, Complications, and Factors Predictive of Response to Treatment with Transvaginal Radiofrequency Ablation for Symptomatic Uterine Myomas.
Santalla-Hernández Á; Naveiro-Fuentes M; Benito-Villena R; López-Criado MS; González-Paredes A; Fernández-Parra J
J Minim Invasive Gynecol; 2022 Jun; 29(6):743-752. PubMed ID: 35091094
[TBL] [Abstract][Full Text] [Related]
16. Comparing the effect of aromatase inhibitor (letrozole) + cabergoline (Dostinex) and letrozole alone on uterine myoma regression,a randomized clinical trial.
Sayyah-Melli M; Mobasseri M; Gharabaghi PM; Ouladsahebmadarek E; Rahmani V
Eur J Obstet Gynecol Reprod Biol; 2017 Mar; 210():257-264. PubMed ID: 28076829
[TBL] [Abstract][Full Text] [Related]
17. Uterine artery embolization for the treatment of symptomatic myomas in Brazilian women.
Sena-Martins M; Roteli-Martins CM; Tadini V; de Souza GA; Kisilevzky N; Lazar Junior F
Sao Paulo Med J; 2003 Sep; 121(5):185-90. PubMed ID: 14666289
[TBL] [Abstract][Full Text] [Related]
18. Relationship of myoma cell size and menopausal status in small uterine leiomyomas.
Cramer SF; Marchetti C; Freedman J; Padela A
Arch Pathol Lab Med; 2000 Oct; 124(10):1448-53. PubMed ID: 11035573
[TBL] [Abstract][Full Text] [Related]
19. A Fast 3-Dimensional Magnetic Resonance Imaging Reconstruction for Surgical Planning of Uterine Myomectomy.
Lee SR; Kim YJ; Kim KG
J Korean Med Sci; 2018 Jan; 33(2):e12. PubMed ID: 29215821
[TBL] [Abstract][Full Text] [Related]
20. Effects of hormone replacement therapy on postmenopausal uterine myoma.
Colacurci N; De Franciscis P; Cobellis L; Nazzaro G; De Placido G
Maturitas; 2000 May; 35(2):167-73. PubMed ID: 10924843
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
